Effect of Iron Accumulation on Bone Mineral Density in Patients Diagnosed With Transfusion-Dependent Thalassemia

被引:0
作者
Selim, Cem [1 ]
Ciftciler, Rafiye [1 ]
Kucukdiler, Ayse Hilal Eroglu [2 ]
Karadag, Fatma Keklik [3 ]
Soyer, Nur [4 ]
机构
[1] Selcuk Univ Fac Med Practice, Res Hosp, Adult Hematol Dept, Konya, Turkiye
[2] Adnan Menderes Univ, Fac Med Practice & Res Hosp, Adult Hematol Dept, Aydin, Turkiye
[3] Tepecik Training & Res Hosp, Adult Hematol Dept, Izmir, Turkiye
[4] Ege Univ, Fac Med Practice & Res Hosp, Adult Hematol Dept, Izmir, Turkiye
关键词
iron overload; osteoporosis; thalassemia; transferrin saturation; transfusion-dependent thalassemia; TRANSFERRIN SATURATION; OSTEOPOROSIS; FERRITIN; MASS;
D O I
10.1155/ijcp/5411059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Transfusion-dependent thalassemia (TDT) is most commonly caused by defects in beta globin chain production. Iron overload, hypogonadism, vitamin D deficiency, adverse effects of desferrioxamine treatment, and delayed puberty due to loss of bone mass are the main complications of TDT. In the present study, we aimed to investigate bone complications and precursor markers in TDT patients.Materials and Methods: Our retrospective study included 93 patients, aged between 18 and 45, who were followed up in a tertiary care institution and did not have any disease other than TDT. The patients' BMD values and biochemical parameters were compared.Results: Osteoporosis was observed in 33 of 93 patients, and the mean transferrin saturation of patients with osteoporosis was 60%, and the mean transferrin saturation of patients without osteoporosis was 42%. Patients with osteoporosis had transferrin saturation that was observed to be considerably higher than that of the group without osteoporosis (p = 0.006), with an average of 60%.Conclusion: Our investigation has demonstrated that in patients with TDT, elevated transferrin saturation may be a sign of osteoporosis.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Iron chelation therapy for children with transfusion-dependent β-thalassemia: How young is too young?
    Forni, Gian Luca
    Kattamis, Antonis
    Kuo, Kevin H. M.
    Maggio, Aurelio
    Sheth, Sujit
    Taher, Ali T.
    Viprakasit, Vip
    PEDIATRIC BLOOD & CANCER, 2024, 71 (08)
  • [22] Coadministration of silymarin with iron chelators in transfusion-dependent β-thalassemia patients: a systematic review and meta-analysis for effect on iron overload
    Darvishi-Khezri, Hadi
    Naderisorki, Mohammad
    Zahedi, Mohammad
    Mortazavi, Parham
    Tajik, Fatemeh
    Nasirzadeh, Amirreza
    Karami, Hossein
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (11) : 1445 - 1453
  • [23] A Longitudinal Study of Growth and Relation With Anemia and Iron Overload in Pediatric Patients With Transfusion-dependent Thalassemia
    Nokeaingtong, Kwannapas
    Charoenkwan, Pimlak
    Silvilairat, Suchaya
    Saekho, Suwit
    Pongprot, Yupada
    Dejkhamron, Prapai
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (06) : 457 - 462
  • [24] Bone turnover, areal BMD, and bone microarchitecture by second-generation high-resolution peripheral quantitative computed tomography in transfusion-dependent thalassemia
    Das, Liza
    Khadwal, Alka
    Malhotra, Pankaj
    Ghosh, Jayaditya
    Dhiman, Vandana
    Sharma, Vivek
    Singhmar, Shallu
    Ahuja, Chirag Kamal
    Saikia, Uma Nahar
    Bhadada, Sanjay Kumar
    Dutta, Pinaki
    JBMR PLUS, 2024, 8 (11)
  • [25] Quantitative MRI evaluation of iron deposition in patients with transfusion-dependent thalassemia: clinical management insights
    Ning, Xiaojing
    Peng, Fei
    Tan, Siyu
    Tang, Cheng
    Luo, Chaotian
    Xiao, Fangyan
    Zhao, Chen
    Peng, Peng
    EXPERT REVIEW OF HEMATOLOGY, 2024, : 977 - 983
  • [26] Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients
    Smesam, Hasan N. K.
    Albuthabhak, Hasan A. Q.
    Arjmand, Sareh
    Al-Hakeim, Hussein K.
    Siadat, Seyed Omid R.
    HEMOGLOBIN, 2020, 44 (04) : 272 - 277
  • [27] Pulmonary Artery Hypertension in Transfusion-Dependent Thalassemia
    Vineeta Gupta
    Vishnu Vijayakumar
    Priyanka Aggarwal
    Ishan Kumar
    Vikas Agrawal
    Indian Pediatrics, 2024, 61 : 49 - 52
  • [28] Pulmonary Artery Hypertension in Transfusion-Dependent Thalassemia
    Gupta, Vineeta
    Vijayakumar, Vishnu
    Aggarwal, Priyanka
    Kumar, Ishan
    Agrawal, Vikas
    INDIAN PEDIATRICS, 2024, 61 (01) : 49 - 52
  • [29] Efficacy and Safety of Thalidomide in Patients With Transfusion-Dependent Thalassemia
    Chandra, Jagdish
    Parakh, Nupur
    Sidharth
    Singh, Neha
    Sharma, Sunita
    Goel, Manish
    Pemde, Harish
    INDIAN PEDIATRICS, 2021, 58 (07) : 611 - 616
  • [30] iFGF23 Plasma Levels in Transfusion-Dependent β-Thalassemia: Insights into Bone and Iron Metabolism
    Gobbo, Alberto
    Longo, Filomena
    Cattaneo, Camilla Alice
    Verrienti, Martina
    Marzi, Gianluca
    Chamekh, Fatima
    Culcasi, Martina
    Cossu, Alberto
    Zatelli, Maria Chiara
    Ambrosio, Maria Rosaria
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)